FindTrial
Sign In

Finding the Minimal change in value of Six Minute Walk Distance in patients with Breast Cancer.

Estimating the minimal clinically important difference of the six minutes walk distance in patients with breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040699
Enrollment
50
Registered
2022-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

None listed

Sponsors

Manipal University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Breast Cancer stage IIâ??III scheduled for curative intent chemotherapy treatment. 2. ECOG (Eastern Cooperative Oncology Group) performance status 3. Age 18years of age

Exclusion criteria

Exclusion criteria: 1. Any musculoskeletal problems (e.g. knee pain, ankle pain) 2. Comorbidities limiting the 6MWT field testing (eg: cardiac arrhythmias, acute myocardial infarction, angina pectoris, patients with LVEF

Design outcomes

Primary

MeasureTime frame
1) To estimate the minimally clinical important difference (MCID) of six minute walk distance (6MWD) in patients with Breast Cancer using Anchor and Distribution based methods. 2) To evaluate the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) at baseline (pretreatment) and after 16 weeks and to correlate physical domain of the questionnaire with Six minute walk distance (6MWD). Timepoint: Baseline and 16 weeks.—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactRavindra Reddy C

Kasturba medical college

stephen.samuel@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026